TIGIT and hepatocellular carcinoma: TerraFlow revealed that HCC was highly enriched for ICOS+ TRM that frequently expressed PD-1 and/or TIGIT (Figure 2E), suggesting that immune checkpoint blockade of PD1 and/or TIGIT might release inhibition of the already expressed costimulatory molecule ICOS.